EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p.Cys61Gly) variant: a case series

Nataliya Kitsera, Yaroslav Shparyk, Orest Tril, Ihor Protsko, Ivanna Duda, Olha Oleksyak, Andrii Hrynkiv, Irena Dovhanyk, Iryna Hrytsai, Iryna Tril, Halyna Makukh, Alina Kruhlykova und 6 weitere

Frontiers in Endocrinology · 30.06.2026 · 17

DOI: 10.3389/fendo.2026.1859939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 30.06.2026. Verfasst von Nataliya Kitsera und 17 weiteren Autor:innen. Beteiligte Einrichtung: Lviv Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine. Hauptthemen laut MEDLINE: Breast Neoplasms, BRCA1 Protein, Ovarian Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

BRCA1 c.181T>G (p.Cys61Gly) is a pathogenic founder genetic variant prevalent in Central and Eastern Europe. The data on its clinicopathological manifestations in Ukrainian patients remain limited.

Aim

This study aimed to characterize clinical presentation, tumor biology, and family history in Ukrainian women with BRCA1 c.181T>G variant. Materials and methods We conducted a single-centre case series of women with primary breast cancer (BC) and/or ovarian cancer (OC) harbouring BRCA1 c.181T>G genetic variant and treated at Lviv Regional Oncology Treatment and Diagnostic Center (Ukraine) between January 2024 and August 2025. Clinical presentation, tumor pathology, biomarker status, family history, treatment, and outcomes were analysed.

Results

Thirteen women aged 29–81 years (median 35 years) were included in this case series. Early-onset BC was recorded in 10 (76.9%) of patients diagnosed before 40 years. BC was the initial malignancy in 12 (92.3%) patients. OC occurred as a first tumor in 1 (7.7%) and as a subsequent cancer in 4 (30.8%) patients. Multiple malignancies were observed in 61.5% of patients, with intervals of 5–21 years between diagnoses. Family history revealed strong clustering of BC and OC across generations, often involving multiple affected relatives, consistent with hereditary breast and ovarian cancer syndrome phenotype. Among cases with known biomarker status (10/13), 2 were HER2-positive, 4 belonged to luminal-like type, and 4 cases represented triple negative BC. Most cases (10/13, 76.9%) were diagnosed at early tumor growth stage (pT1-2). However, more than half of primary tumors (8 of 13; 61.5%) had positive nodal status (pN1-2) reflecting invasive behaviour of cancer cells.

Conclusions

This Ukrainian case series demonstrates that the BRCA1 c.181T>G genetic variant is associated with early-onset breast cancer, variable tumor biology, frequent multiple primary cancers, and strong familial clustering. These observations support the need for expanded genetic testing, targeted surveillance, and corresponding risk reduction strategies tailored to Ukraine’s BRCA1 founder pathogenic variant landscape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBRCA1 ProteinOvarian NeoplasmsHumansFemaleUkraineAdultMiddle AgedAgedAged, 80 and overGenetic Predisposition to DiseaseBiomarkers, Tumor

Stichwörter der Autor:innen

BRCA1breast cancerc.181T>G variantfamily historygermline varianttumor biology

Substanzen

BRCA1 ProteinBRCA1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Lviv Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine.
  • Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine.
  • Scientific and Medical Genetic Center "LeoGENE", Lviv, Ukraine.
  • Medical laboratory CSD, Kyiv, Ukraine.
  • Ukrainian Association for Precision Medicine, Kyiv, Ukraine.
  • Institute of Molecular Biology and Genetics National Academy of Sciences (NAS) of Ukraine, Kyiv, Ukraine.

Zitieren

APA

Kitsera, N., Shparyk, Y., Tril, O., Protsko, I., Duda, I., Oleksyak, O., Hrynkiv, A., Dovhanyk, I., Hrytsai, I., Tril, I., Makukh, H., Kruhlykova, A., Kozakov, D., Livshun, S., Kobyliak, N., Sobechko, S., Oliyarnyk, M., & Sulaieva, O. (2026). Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p.Cys61Gly) variant: a case series. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1859939

Vancouver

Kitsera N, Shparyk Y, Tril O, Protsko I, Duda I, Oleksyak O, et al. Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p.Cys61Gly) variant: a case series. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1859939

BibTeX
@article{Kitsera2026,
  author = {Kitsera, Nataliya and Shparyk, Yaroslav and Tril, Orest and Protsko, Ihor and Duda, Ivanna and Oleksyak, Olha and Hrynkiv, Andrii and Dovhanyk, Irena and Hrytsai, Iryna and Tril, Iryna and Makukh, Halyna and Kruhlykova, Alina and Kozakov, Denys and Livshun, Sofiia and Kobyliak, Nazarii and Sobechko, Solomiia and Oliyarnyk, Myroslava and Sulaieva, Oksana},
  title = {Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p.Cys61Gly) variant: a case series},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fendo.2026.1859939}
}
Kostenlos starten →